Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lorcaserin Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106631823B details a safe, cost-effective synthesis of lorcaserin intermediates using sodium borohydride reduction, eliminating toxic borane and expensive reagents.